A prospective evaluation of changes in brain structure and cognitive functions in adult stem cell transplant recipients

Brain Imaging and Behavior

Volumn 7, Issue 4, 2013, Pages 478-490

  Correa, D D ^a,b   Root, J C ^a,b   Baser, R ^a   Moore, D ^b   Peck, K K ^a,b   Lis, E ^a,b   Shore, T B ^a,b   Thaler, H T ^a   Jakubowski, A ^a,b   Relkin, N ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cognitive; Hematopoietic stem cell transplantation; Structural neuroimaging; Voxel based morphometry

Indexed keywords

BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FLUDARABINE; MELPHALAN; METHOTREXATE; PREDNISOLONE; RITUXIMAB; TACROLIMUS; THIOTEPA;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; AGED; ARTICLE; BRAIN LATERAL VENTRICLE; BRAIN SIZE; BRAIN VENTRICLE; CANCER CHEMOTHERAPY; CAUDATE NUCLEUS; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAY MATTER; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; MALE; MIDDLE FRONTAL GYRUS; NEUROANATOMY; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RELIABLE CHANGE INDEX; VOXEL BASED MORPHOMETRY; WHOLE BODY RADIATION;

ADULT; ADULT STEM CELLS; AGED; BRAIN; COGNITION; COGNITION DISORDERS; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 84901294764     PISSN: 19317557     EISSN: 19317565     Source Type: Journal    
DOI: 10.1007/s11682-013-9221-8     Document Type: Article

References (64)

1. Accomazzi, V., Lazarowich, R., Barlow, C.J., & Davey, B. (2005). Inventors; Cedara Software Corp., assignee. Image region segmentation system and method. US Patent Application 20050031202.
2. Ahles, T. A., & Saykin, A. J. (2007). Candidate mechanisms for chemotherapy-induced cognitive changes. Nature Reviews. Cancer, 7, 192-201.
3. Ahles, T. A., Tope, D. M., Furstenberg, C., Hahn, D., & Mills, L. (1996). Psychologic and neuropsychologic impact of autologous bone marrow transplantation. Journal of Clinical Oncology, 14, 1457-1462.
4. Ahles, T. A., Saykin, A. J., Noll, W. W., Furstenburg, C. T., Guerin, S., Cole, B., et al. (2003). The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy. Psycho-Oncology, 12, 612-619.
5. Ahles, T. A., Saykin, A. J., McDonald, B. C., et al. (2008). Cognitive function in breast cancer patients prior to adjuvant treatment. Breast Cancer Research and Treatment, 110, 143-152.
6. Ahles, T., Saykin, A., McDonald, B., Li, Y., Furstenberg, C. T., Hanscom, B. S., et al. (2010). Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: Impact of Age and Cognitive Reserve. Journal of Clinical Oncology, 28, 4434-4440.
7. Ahles, T. A., Root, J. C., & Ryan, E. L. (2012). Cancer-and cancer treatment-associated cognitive change: an update on the state of the science. Journal of Clinical Oncology, 30, 3675-3686.
8. Andrykowski, M. A., Schmitt, F. A., Gregg, M. E., Brady, M. J., Lamb, D. G., & Henslee-Downey, P. J. (1992). Neuropsychologic impairment in adult bone marrow transplant candidates. Cancer, 70, 2288-2297.
9. Bartynski, W. S., Zeigler, Z., Spearman, M. P., Lin, L., Shadduck, R. K., & Lister, J. (2001). Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity. American Journal of Neuroradiology, 22, 1901-1914.
10. Booth-Jones, M., Jacobsen, P. B., Ransom, S., & Soety, E. (2005). Characteristics and correlates of cognitive functioning following bone marrow transplantation. Bone Marrow Transplantation, 36, 695-702.
11. Chang, G., Meadows, M. E., Orav, E. J., & Antin, J. H. (2009). Mental status changes after hematopoietic stem cell transplantation. Cancer, 115, 4625-4635.
12. Correa, D. D., Maron, L., Harder, H., Klein, M., Armstrong, C. L., Calabrese, P., et al. (2007). Cognitive functions in primary central nervous system lymphoma: literature review and assessment guidelines. Annals of Oncology, 18, 1145-1151.
13. Correa, D. D., Shi, W., Thaler, H. T., Cheung, A. M., DeAngelis, L. M., & Abrey, L. E. (2008). Longitudinal cognitive follow-up in low grade gliomas. Journal of Neurooncology, 86, 321-327.
14. Correa, D. D., Shi, W., Abrey, L. E., Deangelis, L. M., Omuro, A. M., Deutsch, M. B., et al. (2012). Cognitive functions in primary CNS lymphoma after single or combined modality regimens. Neuro-Oncology, 14, 101-108.
15. DeAngelis, L. M., & Posner, J. B. (2009). Side effects of radiation therapy. In L. M. DeAngelis & J. B. Posner (Eds.), Neurologic Complications of Cancer (2nd ed., pp. 511-555). New York: Oxford University Press.
16. Deprez, S., Amant, F., Yigit, R., Porke, K., Verhoeven, J., Van den Stock, J., et al. (2011). Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired functioning in breast cancer patients. Human Brain Mapping, 32, 480-493.
17. Deprez, S., Amant, F., Smeets, A., Peeters, R., Leemans, A., Van Hecke, W., et al. (2012). Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. Journal of Clinical Oncology, 30, 274-281.
18. Devine, S. M., Carter, S., Soiffer, R. J., Pasquini, M. C., Hari, P. N., Stein, A., et al. (2011). Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials network protocol 0303. Biology of Blood and Marrow Transplantation, 9, 1343-1351.
19. Dietrich, J., Han, R., Yang, Y., et al. (2006). CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and vivo. Journal of Biology, 5, 1-23.
20. Dietrich, J., Monje, M., Wefel, J., & Meyers, C. (2008). Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy. The Oncologist, 13, 1285-1295.
21. Ferguson, R. J., McDonald, B. C., Saykin, A. J., & Ahles, T. A. (2007). Brain structure and function differences in monozygotic twins: possible effects of breats cancer chemotherapy. Journal of Clinical Oncology, 25, 3866-3870.
22. Fischl, B., Salat, D. H., Busa, E., Albert, M., Dieterich, M., Haselgrove, C., et al. (2002). Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron, 33, 341-355.
23. Friedman, M. A., Fernandez, M., Wefel, J. S., Myszka, K. A., Champlin, R. E., & Meyers, C. A. (2009). Course of cognitive decline in hematopoietic stem cell transplantation: a within-subjects design. Archives of Clinical Neuropsychology, 24, 689-698.
24. Garrick, R. (2000). Neurologic Complications. In K. Atkinson (Ed.), Clinical bone marrow and blood stem cell transplantation. Cambridge: Cambridge University Press.
25. Hagemeister, F. B. (2002). Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem rescue. Cancer Chemotherapy and Pharmacology, 49, 13-20.
26. Hamadani, M., Craig, M., Phillips, G. S., Abraham, J., Tse, W., Cumpston, A., et al. (2011). Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfanbased reduced toxicity conditioning. Hematological Oncology, 4, 202-210.
27. Harder, H., van Gool, A. R., Cornelissen, J. J., Duivenvoorden, H. J., Eijkenboom, W. M., & van den Bent, M. J. (2005). Assessment of pre-treatment cognitive performance in adult bone marrow or hematopoietic stem cell transplantation patients: a comparative study. European Journal of Cancer, 41, 1007-1016.
28. Harder, H., Duivenvoorden, H. J., van Gool, A. R., Cornelissen, J. J., & van den Bent, M. J. (2006). Neurocognitive functions and quality of life in haematological patients receiving hematopoietic stem cell grafts: a one-year follow-up pilot study. Journal of Clinical and Experimental Neuropsychology, 28, 283-293.
29. Harder, H., van Gool, A. R., Duivenvoorden, H. J., Cornelissen, J. J., Eijkenboom, W. M., Barge, R. M., et al. (2007). Case-referent comparison of cognitive functions in patients receiving hematopoietic stem cell transplantation for haematological malignancies: twoyear follow-up results. European Journal of Cancer, 43, 2052-2059.
30. Inagaki, M., Yoshikawa, E., Matsuoka, Y., Sugawara, Y., Nakano, T., Akechi, T., et al. (2007). Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer, 109, 146-156.
31. Jacobs, S. R., Small, B. J., Booth-Jones, M., Jacobsen, P. B., & Fields, K. K. (2007). Changes in cognitive functioning in the year after hematopoietic stem cell transplantation. Cancer, 110, 1560-1567.
32. Jacobsen, P. B., Garland, L. L., Booth-Jones, M., Donovan, K. A., Thors, C. L., Winters, E., et al. (2004). Relationship of hemoglobin levels to fatigue and cognitive functioning among cancer patients receiving chemotherapy. Journal of Pain and Symptom Management, 28, 7-18.
33. Jacobson, N. S., & Truax, P. (1991). Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology, 59, 12-19.
34. Jakubowski, A. A., Small, T. N., Young, J. W., Kernan, N. A., Castro-Malaspina, H., Hsu, K. C., et al. (2007). T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin. Blood, 110, 4552-4559.
35. Jim, H. S. L., Small, B., Hartman, S., Franzen, J., Millay, S., Phillips, K., et al. (2012). Clinical predictors of cognitive function in adults treated with hematopoietic cell transplantation. Cancer, 118, 3407-3416.
36. Keime-Guibert, F., Napolitano, M., & Delattre, J. Y. (1998). Neurological complications of radiotherapy and chemotherapy. Journal of Neurology, 245, 695-708.
37. Koppelmans, V., de Ruiter, M. B., van der Lijn, F., Boogerd, W., Seynaeve, C., van der Lugt, A., et al. (2012). Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy. Breast Cancer Research and Treatment, 132, 1099-1106.
38. McDonald, B. C., Conroy, S.K., Ahles, T. A., West, J. D., &Saykin, A. J. (2010). Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study. Breast Cancer Research and Treatment, 123, 819-828.
39. McDonald, B.C., Conroy, S.K., Smith, D.J., West, J.D., & Saykin, A.J. (2012a). Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study. Brain Behavior and Immunity, 10.1016/ i. bbi.2012.05.007
40. McDonald, B. C., Conroy, S. K., Ahles, T. A., West, J. D., & Saykin, A. J. (2012b). Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study. Journal of Clinical Oncology, 30, 2500-2508.
41. Meyers, C. A. (1994). Neuropsychological aspects of cancer and cancer treatment. Physical Medicine and Rehabilitation: State of the Art Reviews, 8, 229-241.
42. Meyers, C. A. (2008). How chemotherapy damages the central nervous system. Journal of Biology, 7, 11.
43. Meyers, C. A., Albitar, M., & Estey, E. (2004). Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer, 104, 788-793.
44. Mounier, N., Canals, C., Gisselbrecht, C., Cornelissen, J., Foa, R., Conde, E., et al. (2012). High-dose therapy and autologous stem cell transplantation in first relapse for diffuse large B cell lymphoma in the rituximab era: an analysis based on data from the European Blood and Marrow Transplantation Registry. Biology of Blood and Marrow Transplantation, 18, 788-793.
45. Nestor, S.M., Rupsingh, R., Borrie, M., Smith, M., Accomazzi, V., Wells, J. L., et al. (2008). Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database. Brain, 31, 2443-2454.
46. Nucci, M., Andrade, F., Vigorito, A., Trabasso, P., Aranha, J. F., Maiolino, A., et al. (2003). Infectious complications in patients randomized to receive bone marrow or peripheral blood transplantation. Transplant Infectious Disease, 5, 167-173.
47. Omuro, A.M., Ben-Porat, L. S., Panageas, K. S., Kim, A. K., Correa, D. D., Yahalom, J., et al. (2005). Delayed neurotoxicity in primary central nervous system lymphoma. Archives of Neurology, 62, 1595-1600.
48. Padovan, C. S., Yousry, T. A., Schleuning, M., Holler, E., Kolb, H.-J., & Straube, A. (1998). Neurological and neuroradiological findings in long-term survivors of allogeneic bone marrow transplantation. Annals of Neurology, 43, 627-633.
49. Peper, M., Steinvorth, S., Schraube, P., Fruehauf, S., Haas, R., Kimmig, B. N., et al. (2000). Neurobehavioral toxicity of total body irradiation: a follow-up in long-term survivors. International Journal of Radiation Oncology, Biology, Physics, 46, 303-311.
50. Rzeski, W., Pruskil, S., Macke, A., Felderhoff-Mueser, U., Reiher, A. K., Hoerster, F., et al. (2004). Anticancer agents are potent neurotoxins in vitro and in vivo. Annals of Neurology, 56, 351-360.
51. Schulz-Kindermann, F., Mehert, A., Scherwath, A., Schirmer, L., Schleimer, B., Zander, A. R., et al. (2007). Cognitive function in the acute course of allogeneic hematopoietic stem cell transplantation for hematological malignancies. Bone Marrow Transplantation, 39, 789-799.
52. Seigers, R., Fradell, J.E. (2011). Neurobiological basis of chemotherapy-induced cognitive impairment: a review of rodent research. Neurosci Biobehav Rev, 35, 729-741.
53. Small, B. J., Rawson, K. S., Walsk, E., Jim, H. S., Hughes, T. F., Iser, L., et al. (2011). Catechol-o-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breats cancer survivors. Cancer, 117, 1369-1376.
54. Snider, S., Bashir, R., & Bierman, P. (1994). Neurologic complications after high-dose chemotherapy and autologous bone marrow transplantation for Hodgkin's disease. Neurology, 44, 681-684.
55. Sostak, P., Padovan, C. S., Yousry, T. A., Ledderose, G., Kolg, H.-J., & Straube, A. (2003). Prospective evaluation of neurological complications after allogeneic bone marrow transplantation. Neurology, 60, 842-848.
56. Soutar, R. L., & King, D. J. (1995). Bone marrow transplantation. British Medical Journal, 310, 31-36.
57. Stemmer, S. M., Stears, J. C., Burton, B. S., Jones, R. B., & Simon, J. H. (1994). White matter changes in patients with breast cancer treated with high-dose chemotherapy and autologous bonemarrow support. American Journal of Neuroradiology, 15, 1267-1273.
58. Syrjala, K. L., Dikmen, S., Langer, S. L., Roth-Roemer, S., & Abrams, J. R. (2004). Neuropsychologic changes from before transplantation to 1 year in patients receiving myeloblative allogeneic hematopoietic cell transplant. Blood, 104, 3386-3392.
59. Syrjala, K. L., Artherholt, S. B., Kurlan, B. F., Langer, S. L., Roth-Roemer, S., Elrod, J. B., et al. (2011). Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cance survivors compared to matched controls at 5 years. Journal of Clinical Oncology, 29, 2397-2404.
60. Tukey, J.W. (1977). Exploratory Data Analysis. Addison-Wesley.
61. Vardy, J., Wefel, J. S., Ahles, T., Tannock, I. F., & Schagen, S. B. (2008). Cancer and cancer-therapy related cognitive dysfunction: An international perspective from the Venice cognitive workshop. Annals of Oncology, 19, 623-629.
62. Wefel, J. S., Lenzi, R., Theriault, R. L., Davis, R. N., & Meyers, C. A. (2004). The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer, 100, 2292-2299.
63. Wenz, F., Steinvorth, S., Lohr, F., Fruehauf, S., Wildermuth, S., van Kampen, M., et al. (2000). Prospective evaluation of delayed central nervous system (CNS) toxicity of hyperfractionated total body irradiation (TBI). International Journal of Radiation Oncology, Biology, Physics, 48, 1497-1501.
64. Wood, S. M., Meyers, C. A., Faderi, S., Kantarjian, H. M., Pierce, S. H., & Garcia-Manero, G. (2011). Association of anemia and cognitive dysfunction in patients with acute myelogenous leukemia and myelodysplastic syndrome. American Journal of Hematology, 86, 950-952.